Showing results (41-50 of 280) with videos related to

Sort By:
Pageof 28
Urologic Oncology|April 15, 2023
Heterogeneity of BCG unresponsive bladder cancer clinical trials limits patients' access to novel therapeuticsMichael Chandra, Roger Li, Anil Parwani, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2018
Modeling combination therapy for breast cancer with BET and immune checkpoint inhibitorsXiulan Lai, Andrew Stiff, Megan Duggan, et al.
Clinical Case Reports|September 12, 2022
Sentinel node mapping and biopsy in ectopic axillary breast cancer: A case report and review of the literatureMicah K Harris, Marissa Z Guo, Ann Mangino, et al.
Molecular and Cellular Biology|December 15, 2006
E2f1, E2f2, and E2f3 control E2F target expression and cellular proliferation via a p53-dependent negative feedback loopCynthia Timmers, Nidhi Sharma, Rene Opavsky, et al.
Cancer Research|February 17, 2016
Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib TreatmentAndrew Stiff, Prashant Trikha, Robert Wesolowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2018
Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell FunctionAndrew Stiff, Prashant Trikha, Bethany Mundy-Bosse, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2006
Interleukin-21 enhances NK cell activation in response to antibody-coated targetsJulie M Roda, Robin Parihar, Amy Lehman, et al.
Journal of Pediatric Surgery|July 13, 2013
Heparin-binding EGF-like growth factor (HB-EGF) protects the intestines from radiation therapy-induced intestinal injuryMika A B Matthews, Daniel Watkins, Amanda Darbyshire, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2016
Trajectories of Stress, Depressive Symptoms, and Immunity in Cancer Survivors: Diagnosis to 5 YearsBarbara L Andersen, Neha Godiwala Goyal, Travis D Westbrook, et al.
Cancer Immunology, Immunotherapy : CII|April 28, 2009
Bortezomib pre-treatment prolongs interferon-alpha-induced STAT1 phosphorylation in melanoma cellsGregory B Lesinski, Kristen Benninger, Melanie Kreiner, et al.
Pageof 28